Mystic Pharmaceuticals Receives Japanese Patent For Innovative Pharmaceutical Packaging And Delivery Technology

By: PRLog
AUSTIN, Texas - May 18, 2016 - PRLog -- Mystic Pharmaceuticals, Inc., a privately held, life science technology company, announced today it has received a patent from the Japanese Patent Office for its "Combination Unit Dose Dispensing Container" (Japanese Patent 5898655). Mystic's latest innovation facilitates the development of unit dose packaging and delivery of drugs or biologics that must be reconstituted or combined with another active pharmaceutical ingredient just prior to administration.

"This latest patent expands the global market opportunities for our VRx2™ Delivery Platform by providing pharmaceutical and biotech manufacturers with patient-centric delivery systems which package and automatically reconstitute or combine two or more liquid or powder drug formulations at the time of administration," said Timothy Sullivan, Mystic's Founder and co-inventor of the technology. "This technology will enable the development of new or reformulation of existing pharmaceutical products that were previously not commercially viable," Mr. Sullivan stated.

These latest innovations extend the capabilities of Mystic's VersiDoser® and VRx2™ packaging and delivery platforms enabling the development of new classes of innovative, value-add drug/device combination products for systemic nasal, ophthalmic, sublingual, buccal, dermal and nose to brain routes of non-invasive administration.

Mystic's technology enables pharmaceutical and biotech manufacturers to develop drug/device combination products that can extend or establish market exclusivity and competitive differentiation for new or existing drugs and biologics. The shift to developing value added, patient-centric products benefits the consumer through improved compliance and health outcomes while building brand value for the pharmaceutical manufacturer. Mystic's delivery platforms and products are designed to meet the diverse demands of consumers and pharma manufacturers in globally competitive markets.

About Mystic Pharmaceuticals, Inc.

Mystic Pharmaceuticals® is a life science technology company based in Austin, Texas. Mystic provides patient-centric unit dose packaging and delivery technology for pharmaceuticals, biopharmaceuticals and biologics for intranasal, nose-to-brain, ophthalmic, sublingual, and otic product applications. For more information, please visit the Mystic website at: http://www.mysticpharmaceuticals.com.

Contact
Melissa Brandt
***@mysticpharmaceuticals.com

Photos: (Click photo to enlarge)

Mystic Pharmaceuticals, Inc. Logo

Read Full Story - Mystic Pharmaceuticals Receives Japanese Patent For Innovative Pharmaceutical Packaging And Delivery Technology | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.